We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Atrium Innovations Buys Dietary Supplement Maker Seroyal International

January 4, 2011: 04:19 AM EST

Canadian nutrition supplement maker Atrium Innovations Inc. has acquired Ontario-based Seroyal International, a provider of premium dietary supplement brands targeting healthcare practitioners channels in Canada and in the U.S. Seroyal’s annual revenues are about US$40 million. Ninety percent of Seroyal’s sales come from three main products: Genestra, Unda and Pharmax. Another brand, the joint venture-owned CoreLab, is a health food store brand sold in the U.S. Atrium acquired Seroyal for a total cash consideration of US$110 million plus future earn-out payments. Atrium markets a portfolio of dietary supplements for the health and nutrition industry in more than 35 countries, primarily in North America and Europe. According to Atrium CEO, the acquisition ”adds premium, high margin and complementary brands” to Atrium’s product line.

Amélie Germain, "Atrium Innovations acquired Seroyal – a North American leader in providing well recognized and high quality brands to healthcare practitioners", News release, Atrium Innovations, January 04, 2011, © Atrium Innovations
Collaboration & Networks
Examples & Case Studies
North America
Companies, Organizations
Deals, M&A, JVs, Licensing
Market News
Press Release
Products & Brands
Developed by Yuri Ingultsov Software Lab.